Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial
Open accessThe DOI matches its Crossref record.
Abstract
OBJECTIVES: To determine the effects of adding an oxytocin infusion to bolus oxytocin on blood loss at elective caesarean section. DESIGN: Double blind, placebo controlled, randomised trial, conducted from February 2008 to June 2010. SETTING: Five maternity hospitals in the Republic of Ireland. PARTICIPANTS: 2069 women booked for elective caesarean section at term with a singleton pregnancy. We excluded women with placenta praevia, thrombocytopenia, coagulopathies, previous major obstetric haemorrhage (>1000 mL), or known fibroids; women receiving anticoagulant treatment; those who did not understand English; and those who were younger than 18 years. INTERVENTION: Intervention group: intravenous slow 5 IU oxytocin bolus over 1 minute and additional 40 IU oxytocin infusion in 500 mL of 0.9% saline solution over 4 hours (bolus and infusion). Placebo group: 5 IU oxytocin bolus over 1 minute and 500 mL of 0.9% saline solution over 4 hours (placebo infusion) (bolus only). Main outcomes Major obstetric haemorrhage (blood loss >1000 mL) and need for an additional uterotonic agent. RESULTS: We found no difference in the occurrence of major obstetric haemorrhage between the groups (bolus and infusion 15.7% (158/1007) v bolus only 16.0% (159/994), adjusted odds ratio 0.98, 95% confidence intervals 0.77 to 1.25, P=0.86). The need for an additional uterotonic agent in the bolus and infusion group was lower than that in the bolus only group (12.2% (126/1033) v 18.4% (189/1025), 0.61, 0.48 to 0.78, P<0.001). Women were less likely to have a major obstetric haemorrhage in the bolus and infusion group than in the bolus only group if the obstetrician was junior rather than senior (0.57, 0.35 to 0.92, P=0.02). CONCLUSION: The addition of an oxytocin infusion after caesarean delivery reduces the need for additional uterotonic agents but does not affect the overall occurrence of major obstetric haemorrhage. Trial Registration Current Controlled Trials ISRCTN17813715.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Evidence-based surgery for cesarean delivery: an updated systematic review
Dahlke, J. D., Mendez-Figueroa, H., Rouse, D. J., Berghella, V., Baxter, J. K., & Chauhan, S. P. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.02.043 · Cited by 277
Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery
Sentilhes, L., Sénat, M. V., Le Lous, M., Winer, N., Rozenberg, P., Kayem, G., Verspyck, E., Fuchs, F., Azria, E., Gallot, D., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2028788 · Cited by 276
The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?
Weeks, A. (2015) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13098 · Cited by 192
Postpartum haemorrhage: prevention and treatment
Sentilhes, L., Merlot, B., Madar, H., Sztark, F., Brun, S., & Deneux-Tharaux, C. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1245135 · Cited by 153
The use of meta-analytic statistical significance testing
Polanin, J. R., & Pigott, T. D. (2015) · Research Synthesis Methods · doi:10.1002/jrsm.1124 · Cited by 78
Metadata
- Authors
- Sheehan, S. R., Montgomery, A. A., Carey, M., McAuliffe, F. M., Eogan, M., Gleeson, R., Geary, M., Murphy, D. J., & The ECSSIT Study Group
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2011-08-01
- Volume
- 343
- Issue
- aug01 1
- Pages
- d4661-d4661
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W1978293433
- Cited by
- 119
- References
- 0
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. https://app.cochat.ai/papers/10.1136/bmj.d4661
- The paper
- Sheehan, S. R., Montgomery, A. A., Carey, M., McAuliffe, F. M., Eogan, M., Gleeson, R., Geary, M., Murphy, D. J., & The ECSSIT Study Group. (2011). Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial. BMJ. https://doi.org/10.1136/bmj.d4661
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.